Kura Oncology (KURA) Operating Expenses (2010 - 2026)
Kura Oncology (KURA) posted quarterly Operating Expenses of $97.1 million for Q1 2026, up 23.19% year-over-year from $78.8 million in Q1 2025, and up 23.19% quarter-over-quarter from $78.8 million in Q1 2025.
Kura Oncology (KURA) Operating Expenses (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Operating Expenses for 17 consecutive years, with $97.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 23.19% year-over-year to $97.1 million; the TTM figure through Mar 2026 stood at $97.1 million (down 64.23% YoY), while the FY2025 annual figure was $371.1 million, up 50.2% from the prior year.
- Operating Expenses advanced to $97.1 million in Q1 2026 per KURA's latest filing, from $78.8 million in the prior quarter.
- Across five years, Operating Expenses topped out at $97.1 million in Q1 2026 and bottomed at $32.8 million in Q1 2022.
- Historically, Operating Expenses has averaged $52.0 million across 5 years, with a median of $44.6 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses rose 5.01% — and 2024, when it jumped 63.25%.
- Kura Oncology's Operating Expenses stood at $35.2 million in 2022, then soared by 33.01% to $46.8 million in 2023, then jumped by 63.25% to $76.3 million in 2024, then rose by 3.24% to $78.8 million in 2025, then grew by 23.19% to $97.1 million in 2026.
- Business Quant data shows KURA's Operating Expenses at $97.1 million in Q1 2026, $78.8 million in Q1 2025, and $76.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | 93.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.88 Mn |
| Mar 31, 2026 | 97.08 Mn |
| Mar 31, 2025 | 78.81 Mn |
| Dec 31, 2024 | 76.34 Mn |
| Sep 30, 2024 | 59.88 Mn |
| Jun 30, 2024 | 56.40 Mn |
| Mar 31, 2024 | 54.45 Mn |
| Dec 31, 2023 | 46.76 Mn |
| Sep 30, 2023 | 42.47 Mn |
| Jun 30, 2023 | 40.00 Mn |
| Mar 31, 2023 | 36.57 Mn |
| Dec 31, 2022 | 35.16 Mn |
| Sep 30, 2022 | 36.59 Mn |
| Jun 30, 2022 | 35.33 Mn |
| Mar 31, 2022 | 32.78 Mn |
| Dec 31, 2021 | 33.04 Mn |
| Sep 30, 2021 | 33.68 Mn |
| Jun 30, 2021 | 33.65 Mn |
| Mar 31, 2021 | 30.90 Mn |
| Dec 31, 2020 | 26.33 Mn |